Display options
Cite
Sharifipour F, Zeraati A, Sahebari M, et al. Association of urinary lipocalin-2 with lupus nephritis. Iran J Basic Med Sci. 2013;16(9):1011-5
Sharifipour, F., Zeraati, A., Sahebari, M., Hatef, M., Naghibi, M., Rezaieyazdi, Z., Mahmoudi, M., Azarian, A. A., Mirfeizi, Z., & Samadi, K. (2013). Association of urinary lipocalin-2 with lupus nephritis. Iranian journal of basic medical sciences, 16(9), 1011-5.
Sharifipour, Farzaneh, et al. "Association of urinary lipocalin-2 with lupus nephritis." Iranian journal of basic medical sciences vol. 16,9 (2013): 1011-5.
Sharifipour F, Zeraati A, Sahebari M, Hatef M, Naghibi M, Rezaieyazdi Z, Mahmoudi M, Azarian AA, Mirfeizi Z, Samadi K. Association of urinary lipocalin-2 with lupus nephritis. Iran J Basic Med Sci. 2013 Sep;16(9):1011-5. PMID: 24171081; PMCID: PMC3804839.
Copy Download .nbib Format: NLM
Share it on

Iran J Basic Med Sci. 2013 Sep;16(9):1011-5.

Association of urinary lipocalin-2 with lupus nephritis.

Iranian journal of basic medical sciences

Farzaneh Sharifipour, Abbasali Zeraati, Maryam Sahebari, Mohammadreza Hatef, Masih Naghibi, Zahra Rezaieyazdi, Mahmoud Mahmoudi, Amir Abbas Azarian, Zahra Mirfeizi, Katayoun Samadi

PMID: 24171081 PMCID: PMC3804839

Abstract

OBJECTIVE(S): Lupus nephritis (LN) is the main cause of mortality and disability in systemic lupus erythematosus (SLE) patients. Therefore, utilizing a reliable and non-invasive method for serial measurements of renal function seems to be necessary. The aim of this study was to evaluate the role of urinary lipocalin-2 as a biomarker of renal involvement in SLE patients.

MATERIALS AND METHODS: Fifty two lupus patients in this cross sectional study were divided into two groups: patients with and without nephritis. For each group, urinary lipocalin-2, values were measured and reported according to urinary lipocalin-2/creatinine. Urinary lipocalin-2/creatinine sensitivity and specificity for identifying biopsy-proven nephritis were calculated, and a receiver operating characteristic (ROC) curve was constructed. Results : The mean urinary lipocalin-2/creatinine value of patients with biopsy-proven LN was 2.99 ± 4.1 ng/mg, and in non-LN patients was 1.16 ± 1.27 ng/mg. Urinary lipocalin-2/creatinine levels in LN patients were significantly higher than those in non-LN patients (P- Value = 0.03). In LN patients, urinary lipocalin-2/creatinine significantly correlated with proteinuria (r = 0.68; P = 0.0001). Using a cutoff value of 0.896 ng/mg, urinary lipocalin-2/creatinine had a sensitivity of 89.7% and a specificity of 39.1% for identifying SLE patients with biopsy-proven LN. The area under the ROC curve was 0.664 ± 0.076 with a 95% confidence interval of 0.52-0.81 (P=0.04). Analysis of variance showed that urinary lipocalin-2/creatinine is the same in different classes of LN (P-value=0.28).

CONCLUSION: An important clinical conclusion is that measurement of urinary Lipocalin-2 may result in earlier diagnosis of LN.

Keywords: Lupus; Nephritis; SLE; Urinary Lipocalin- 2

References

  1. J Clin Invest. 2005 Mar;115(3):610-21 - PubMed
  2. Best Pract Res Clin Rheumatol. 2005 Oct;19(5):785-98 - PubMed
  3. Nephrol Dial Transplant. 2008 Jan;23(1):414-6 - PubMed
  4. J Am Soc Nephrol. 2003 Oct;14(10):2534-43 - PubMed
  5. Scand J Clin Lab Invest Suppl. 2008;241:89-94 - PubMed
  6. Lancet. 2005 Apr 2-8;365(9466):1231-8 - PubMed
  7. Curr Opin Rheumatol. 2005 Sep;17(5):543-9 - PubMed
  8. Autoimmun Rev. 2008 Jan;7(3):229-34 - PubMed
  9. J Biomed Biotechnol. 2010;2010:638413 - PubMed
  10. Arthritis Rheum. 2006 Aug;54(8):2577-84 - PubMed
  11. Arthritis Rheum. 2007 Jun;56(6):1894-903 - PubMed
  12. Pediatr Nephrol. 2008 Mar;23(3):403-12 - PubMed
  13. J Rheumatol. 2006 Aug;33(8):1464-6 - PubMed
  14. J Am Soc Nephrol. 2009 Aug;20(8):1823-32 - PubMed
  15. J Rheumatol. 2000 Dec;27(12):2822-6 - PubMed

Publication Types